Richard Lafayette

Publications

• Red blood cell transfusion use in patients with chronic kidney disease. Gill KS, Muntner P, Lafayette RA, Petersen J, Fink JC, Gilbertson DT, Bradbury BD. Nephrol Dial Transplant. 2013
• The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis. Dinner S, Witteles W, Witteles R, Lam A, Arai S, Lafayette R, George TI, Schrier SL, Liedtke M. Br J Haematol. 2013; 161 (3): 367-72
• Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies. Varr BC, Liedtke M, Arai S, Lafayette RA, Schrier SL, Witteles RM. J Heart Lung Transplant. 2012; 31 (3): 325-31
• More than a frog in the throat: a case series and review of localized laryngeal amyloidosis. Stevenson R, Witteles R, Damrose E, Arai S, Lafayette RA, Schrier S, Afghahi A, Liedtke M. Arch Otolaryngol Head Neck Surg. 2012; 138 (5): 509-11
• Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach. Sigdel TK, Woo SH, Dai H, Khatri P, Li L, Myers B, Sarwal MM, Lafayette RA. Clin J Am Soc Nephrol. 2011; 6 (12): 2775-84
• Serum relaxin levels and kidney function in late pregnancy with or without preeclampsia. Lafayette RA, Hladunewich MA, Derby G, Blouch K, Druzin ML, Myers BD. Clin Nephrol. 2011; 75 (3): 226-32
• Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion. Welles CC, Tambra S, Lafayette RA. Am J Kidney Dis. 2010; 55 (1): 148-51
• Imatinib in the treatment of nephrogenic systemic fibrosis. Chandran S, Petersen J, Jacobs C, Fiorentino D, Doeden K, Lafayette RA. Am J Kidney Dis. 2009; 53 (1): 129-32
• Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients. Chan K, Moran J, Hlatky M, Lafayette R. Nephrol Dial Transplant. 2009; 24 (6): 1956-62
• Course of preeclamptic glomerular injury after delivery. Hladunewich MA, Myers BD, Derby GC, Blouch KL, Druzin ML, Deen WM, Naimark DM, Lafayette RA. Am J Physiol Renal Physiol. 2008; 294 (3): F614-20
• Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients. Chan KE, Lafayette RA, Whittemore AS, Hlatky MA, Moran J. Nephrol Dial Transplant. 2008; 23 (9): 2948-56
• Prediction of early progression in recently diagnosed IgA nephropathy. Lemley KV, Lafayette RA, Derby G, Blouch KL, Anderson L, Efron B, Myers BD. Nephrol Dial Transplant. 2008; 23 (1): 213-22
• Pathophysiology of the clinical manifestations of preeclampsia. Hladunewich M, Karumanchi SA, Lafayette R. Clin J Am Soc Nephrol. 2007; 2 (3): 543-9
• Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Lentine KL, Parsonnet J, Taylor I, Wrone EM, Lafayette RA. Clin Exp Nephrol. 2006; 10 (1): 55-62
• Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial. Hladunewich MA, Derby GC, Lafayette RA, Blouch KL, Druzin ML, Myers BD. Obstet Gynecol. 2006; 107 (4): 886-95
• Renal tubular injury associated with anagrelide use. Rodwell GE, Troxell ML, Lafayette RA. Nephrol Dial Transplant. 2005; 20 (5): 988-90
• The kidney in preeclampsia. Lafayette R, Kidney Int. 2005; 67 (3): 1194-203
• Examining chronic kidney disease management in a single center. Lafayette RA, Lai G. Clin Nephrol. 2004; 62 (4): 260-6
• The dynamics of glomerular filtration in the puerperium. Hladunewich MA, Lafayette RA, Derby GC, Blouch KL, Bialek JW, Druzin ML, Deen WM, Myers BD. Am J Physiol Renal Physiol. 2004; 286 (3): F496-503
• Podocytopenia and disease severity in IgA nephropathy. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD. Kidney Int. 2002; 61 (4): 1475-85
• How does knocking out angiotensin II activity reduce renal injury in mice? Lafayette RA, Am J Kidney Dis. 2000; 35 (1): 166-72
• The dynamics of glomerular filtration after Caesarean section. Lafayette RA, Malik T, Druzin M, Derby G, Myers BD. J Am Soc Nephrol. 1999; 10 (7): 1561-5
• Nature of glomerular dysfunction in pre-eclampsia. Lafayette RA, Druzin M, Sibley R, Derby G, Malik T, Huie P, Polhemus C, Deen WM, Myers BD. Kidney Int. 1998; 54 (4): 1240-9
• Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH. J Am Soc Nephrol. 1998; 9 (4): 692-8
• Renal artery stenosis in kidney transplants. Fervenza FC, Lafayette RA, Alfrey EJ, Petersen J. Am J Kidney Dis. 1998; 31 (1): 142-8
• Acute renal failure due to postinfectious glomerulonephritis during pregnancy. Fervenza F, Green A, Lafayette RA. Am J Kidney Dis. 1997; 29 (2): 273-6
• Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH. N Engl J Med. 1997; 336 (12): 828-34
• Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Lafayette RA, Paré G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA. Clin Nephrol. 1997; 48 (3): 159-64
• Profound hypophosphatemia and isolated hyperphosphaturia in two cases of multiple myeloma. Dash T, Parker MG, Lafayette RA. Am J Kidney Dis. 1997; 29 (3): 445-8
• Preventing disease progression in chronic renal failure. Lafayette RA, Am Fam Physician. 1995; 52 (6): 1783-91
• Increased serum creatinine in the absence of renal failure in profound hypothyroidism. Lafayette RA, Costa ME, King AJ. Am J Med. 1994; 96 (3): 298-9
• Effects of angiotensin II receptor blockade on remnant glomerular permselectivity. Mayer G, Lafayette RA, Oliver J, Deen WM, Myers BD, Meyer TW. Kidney Int. 1993; 43 (2): 346-53
• The effects of blood pressure reduction on cyclosporine nephrotoxicity in the rat. Lafayette RA, Mayer G, Meyer TW. J Am Soc Nephrol. 1993; 3 (12): 1892-9
• Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. Lafayette RA, Mayer G, Park SK, Meyer TW. J Clin Invest. 1992; 90 (3): 766-71